FedCircuitBlog

This morning the Federal Circuit issued two precedential opinions in patent cases appealed from the Patent Trial and Appeal Board, two nonprecedential opinions in another patent case appealed from the Patent Trial and Appeal Board and an employment case, a Rule 36 judgment, and one erratum. Here are the introductions to the opinions and links to the relevant orders.

In this article, we highlight two scholarly articles related to the Federal Circuit.

• Eli Lilly v. Teva: Generic Companies Infringe under Akamai IV in Case of Divided Infringement by Christopher M. Holman
• Design Patent Law’s Identity Crisis by Peter S. Menell and Ella Corren

Here are the details.

Here is an update on recent en banc activity at the Federal Circuit in patent cases. Highlights include a new petition raising a question related to claim construction; new invitations to respond to petitions raising questions related to novelty and non-obviousness; and the denial of two petitions raising questions related to design patent law and joinder in inter partes review proceedings. Here are the details.

This morning the Federal Circuit issued one nonprecedential opinion in a patent case. Here is the introduction to the opinion.

Here is a report on recent news and commentary related to the Federal Circuit and its cases, including comments on recent remarks by former Federal Circuit Chief Judge Randall Rader and an article discussing the “[m]ost important patent cases of 2019 thus far.”

Here is a report on recent news and commentary related to the Federal Circuit and its cases, including two articles commenting on this week’s oral arguments, another article commenting on a recent Federal Circuit opinion related to personalized medicine, and another reporting on Thryv, Inc. v. Click-to-Call Technologies, LP, a case the Supreme Court will hear this upcoming term.